Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPIC: Outpatient Talc Pleurodesis
NCT03973957Unknown
- Sponsor
- Cooper University Health Care
- Start
- May 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Cooper University Health Care. Primary endpoint: Time to pleurodesis at 1 month. Status: unknown.
Beyond the preview
Go deeper on NCT03973957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03973957.